It may be mentioned here that HDT Bio had signed an agreement with Gennova Biopharmaceuticals in July 2020 for jointly developing a potential Covid vaccine, using the messenger or mRNA technology.

When contacted, an Emcure spokesperson told media: “The licence agreement, which is the subject matter of the suit, is between Gennova Biopharmaceuticals and HDT. Emcure Pharma has no connection whatsoever with the matter. Emcure has been legally advised that no suit lies against it; and it has been wrongly joined as a party. The company is initiating steps to have the claims dismissed”.

A Gennova spokesperson stated: “We state that there is no legal merit in the suit. We assert that there is no contravention of breach on any contractual obligations or provisions of law. We shall defend such frivolous litigation vigorously”.

(With inputs from agencies)